bathocuproine disulfonate has been researched along with uric acid in 1 studies
| Studies (bathocuproine disulfonate) | Trials (bathocuproine disulfonate) | Recent Studies (post-2010) (bathocuproine disulfonate) | Studies (uric acid) | Trials (uric acid) | Recent Studies (post-2010) (uric acid) |
|---|---|---|---|---|---|
| 103 | 0 | 25 | 27,980 | 1,717 | 9,982 |
| Protein | Taxonomy | bathocuproine disulfonate (IC50) | uric acid (IC50) |
|---|---|---|---|
| Solute carrier family 2, facilitated glucose transporter member 9 | Homo sapiens (human) | 300 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bagnati, M; Bellomo, G; Berto, S; Gosmaro, F; Prenesti, E | 1 |
1 other study(ies) available for bathocuproine disulfonate and uric acid
| Article | Year |
|---|---|
Measurement of total antioxidant capacity of human plasma: setting and validation of the CUPRAC-BCS method on routine apparatus ADVIA 2400.
Topics: Antioxidants; Ascorbic Acid; Calibration; Cations, Divalent; Cations, Monovalent; Copper; Diabetes Mellitus; Humans; Hydrogen-Ion Concentration; Oxidation-Reduction; Oxidative Stress; Phenanthrolines; Photometry; Reference Standards; Renal Dialysis; Sensitivity and Specificity; Uric Acid | 2013 |